Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 49-54, January 2010

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Predicting Worsening Renal Function in Acute Decompensated Heart Failure

  • Arash Aghel, MD

      Affiliations

    • Education Institute, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Kevin Shrestha, AB

      Affiliations

    • Education Institute, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Wilfried Mullens, MD

      Affiliations

    • Ziekenhuis Oost Limburg, Genk, Belgium
  • ,
  • Allen Borowski, RDCS

      Affiliations

    • Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • W.H. Wilson Tang, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH
    • Corresponding Author InformationReprint requests: W. H. Wilson Tang, MD, Heart and Vascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195. Tel: (216) 444-2121; Fax: (216) 445-6165.

Received 5 March 2009; received in revised form 2 July 2009; accepted 9 July 2009. published online 24 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 All decisions regarding this manuscript were made by a guest editor.

 Supported in part by the American Society of Echocardiography Sonographers' Grant (A.B.) and the National Institute of Health CTSA Award (UL1-RR024989). Dr. Tang has received research support from Abbott Laboratories and is a consultant for Medtronic Inc and Merck & Co.

PII: S1071-9164(09)00680-0

doi:10.1016/j.cardfail.2009.07.003

Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 49-54, January 2010